T/SXJP 061-2023 Active Group standards

T/SXJP 061-2023 Anti-HPV Biological Dermal Patch

Publish Date: 1970-01-01 Implement Date: 1970-01-01 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us

Price: $ 29.00

Out of stock

Basic Information

Standard Code: T/SXJP 061-2023

Standard Type: Group standards

Standard Status: Active

is_force_gb: no

CCS Name: Medical hygiene products

ICS Name: Medical materials

Publish Date: 1970-01-01

Implement Date: 1970-01-01

Scope

Main technical content: 3 Terms and Definitions The following terms and definitions apply to this document. 3.1 Acid-anhydride Modified Bovine β-Lactoglobulin: Bovine β-lactoglobulin modified with 3-hydroxy-isophthalic anhydride. 4 Requirements 4.1 Appearance The product should be a uniform brown, viscous colloid with no visible foreign matter, impurities, lumps, or odor when observed with the naked eye. 4.2 Content The content of acid-anhydride modified bovine β-lactoglobulin should be specified. 4.3 Physical Properties 4.5 Microbiological Limits